Champions Oncology Inc (FRA:2I3)
€ 3.9 0.06 (1.56%) Market Cap: 56.35 Mil Enterprise Value: 60.26 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Q4 2022 Champions Oncology Inc Earnings Call Transcript

Jul 21, 2022 / 08:30PM GMT
Release Date Price: €8.05 (-6.94%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Champions Oncology fourth-quarter fiscal year 2022 earnings call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Ronnie Morris, CEO of Champions Oncology. Sir, the floor is yours.

Ronnie Morris
Champions Oncology, Inc. - President & CEO

Good afternoon. I am Ronnie Morris, CEO of Champions Oncology. Joining me today is David Miller, our Chief Financial Officer. Thank you for joining us for our quarterly earnings call.

Before I begin, I'll remind you that we'll be making forward-looking statements during today's call and that actual results could differ materially from what is described in those statements. Additional information on factors that could cause results to differ is available on our Form 10-Q and Form 10-K.

A reconciliation of non-GAAP financial measures that may be discussed during the call to GAAP financial measures is available in the earnings release.

Overall, we had another year of significant progress, successfully

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot